All In MedTech

Device Trial Radar · NCT07720557

PulseMagic™ TrueForce™ PAF NMPA Study

A Study of Pulsed Field Ablation With the PulseMagic™ TrueForce™ Catheter and PulseMagic™ PFA Generator for the Treatment of Paroxysmal Atrial Fibrillation (PFATrueForce)

Last checked: Nov 20, 2026Latest source record: Jul 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Jul 10, 2026

Primary completion

Jul 1, 2028

Study completion Nov 30, 2028

Sponsor

Lead sponsor
Shanghai MicroPort EP MedTech Co., Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Jul 22, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical investigation is intended to demonstrate safety and effectiveness of the PulseMagic™ TrueForce™ Ablation Catheter and the PulseMagic™Pulse Field Ablation (PFA) Generator, and Columbus™ 3D EP Navigation System with Pulsed Field Ablation Software for the treatment of symptomatic, recurrent, drug refractory paroxysmal atrial fibrillation (PAF).

Conditions

  • Atrial Fibrillation (AF)
  • Paroxysmal AF
  • Drug Refractory Paroxysmal Atrial Fibrillation
  • Atrial Arrhythmia

Interventions

  • PFA Ablation catheterDevice

    Deliver PF energy using the PulseMagic™ PFA system

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The success rate within 12 months after operation treatment without AADsTime frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College

    Beijing, Beijing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.